Biomedical Technology

BayVax Biotech Limited

🚫 No Website Found 🏢 HKSTP Source
52 Potential

Decision Maker

Ms. Meiyu Chen
may.chen@bayvaxbio.com
56073630
Cubicle 1 (S37-S40), 6/F, Building 17W No. 17 Science Park West Avenue Hong Kong Science Park,Pak Shek Kok,N.T.
Raw Description
Product | We have developed a systematic vaccine development platform. Peptide-based formulation is optimal for neoantigen delivery. Adjuvant is another essential component, while current peptide-adjuvant isolated formulation could be improved further. We have developed a novel vaccine formulation BVX-001 to conjugate adjuvant and peptide together, forming nanoparticles in water solution. BVX-001 could induce significantly higher neoantigen specific T cell response than current standard formulations. | Antigen prediction algorithm and vaccine formulation are two wings for personalised neoantigen vaccine development to take flight. Instantly, our BayVax antigen prediction algorithm is aimed to predict neoantigen candidates from mutation sequencing information and then screen out the immunogenic neoantigen candidates. At the same time, our BayVax vaccine formulation is the optimal formulation to deliver the neoantigen candidates from the antigen prediction algorithm. This platform can also be used to develop other vaccines. || BayVax Biotech Limited develops synthetic vaccines for preventing or treating all immune related diseases. Our world-class team and ample resources support every step of the biotech success journey. Our vaccine technology is licensed from the University of Hong Kong. We are committed to eliminating pain and benefiting mankind with a new generation of vaccine technology. | Description | A biopharmaceutical company dedicated to developing synthetic vaccines against cancers and other diseases

Strategic Analysis

Executive Brief

BayVax Biotech is a biopharmaceutical firm specializing in synthetic, peptide-based neoantigen vaccines. Their core innovation, the BVX-001 platform, utilizes a proprietary algorithm to predict immunogenic mutations and a nanoparticle formulation to conjugate adjuvants with peptides. Their work centers on high-precision molecular assembly and biochemical characterization to drive T-cell responses against cancers.

Strategic Fit & Lead Score

Lead Score: 52 (Research & Analytical Engineering)

Why this Score? While BayVax is a "soft-matter" biotech company, their engineering bottlenecks reside in analytical precision and ultra-pure processing. 6C's Boron Doped Diamond (BDD) technology offers the world's most sensitive electrochemical sensing platform for peptide/protein detection, and our high-purity Hydrogen systems are essential for the Mass Spectrometry (LC-MS/MS) workflows they use for neoantigen discovery.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Peptide Monitoring BDD Electrodes Boron Doped Diamond (BDD) has the widest electrochemical potential window. It enables real-time, label-free detection of peptide-adjuvant conjugation without electrode fouling (common in carbon/gold).
Ultra-Pure Analytics 9N H2 Generators Support for LC-MS/MS (Liquid Chromatography-Mass Spectrometry) used in their "Antigen prediction algorithm" validation. High-purity hydrogen ensures a lower noise floor for identifying rare mutation sequences.
Formulation Quality PCD Optical Windows Polycrystalline Diamond (PCD) windows for high-throughput Raman or FTIR spectroscopy. Diamond's chemical inertness allows for "in-line" monitoring of nanoparticle formation in aggressive aqueous solutions.
Sterilization Tech BDD Water Treatment Electrochemical Advanced Oxidation Processes (EAOP) using BDD can eliminate endotoxins and organic contaminants in the water used for the BVX-001 formulation without chemical additives.
Bio-Sensing R&D SCD Substrates Single Crystal Diamond (SCD) with Ra < 1nm for developing next-generation Field Effect Transistor (FET) biosensors to measure T-cell response kinetics at the molecular level.

Engagement Hooks

  • Technical Question: "During the nanoparticle conjugation phase of BVX-001, how are you currently monitoring the efficiency of the peptide-adjuvant bond in real-time, and does electrode fouling limit your electrochemical sensitivity?"
  • Value Statement: "6C's Boron Doped Diamond technology provides the electrochemical stability and wide potential window necessary to characterize complex neoantigen formulations that traditional gold or platinum sensors simply cannot resolve."